Search research articles
Contact Us
Filters
Showing results (91-100 of 114) with videos related to
Page
of 12
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 25, 2000
First-line high-dose chemotherapy +/- radiation therapy in patients with metastatic germ-cell cancer and brain metastases
C Kollmannsberger, C Nichols, M Bamberg, et al.
Cancer
|
April 3, 2001
Extragonadal seminoma: an international multicenter analysis of prognostic factors and long term treatment outcome
C Bokemeyer, J P Droz, A Horwich, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 25, 2011
The validation of matrix metalloproteinase-9 mRNA gene expression as a predictor of outcome in patients with metastatic gastric cancer
S-E Al-Batran, C Pauligk, R Wirtz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 17, 2001
Second-line chemotherapy in patients with relapsed extragonadal nonseminomatous germ cell tumors: results of an international multicenter analysis
J T Hartmann, L Einhorn, C R Nichols, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 26, 2003
Analysis of salvage treatments for germ cell cancer patients who have relapsed after primary high-dose chemotherapy plus autologous stem cell support
C Kollmannsberger, N Schleucher, O Rick, et al.
Journal of the National Cancer Institute
|
November 22, 2001
Incidence of metachronous testicular cancer in patients with extragonadal germ cell tumors
J T Hartmann, S D Fossa, C R Nichols, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 22, 2003
Long-term results of first-line sequential high-dose etoposide, ifosfamide, and cisplatin chemotherapy plus autologous stem cell support for patients with advanced metastatic germ cell cancer: an extended phase I/II study of the German Testicular Cancer Study Group
H-J Schmoll, C Kollmannsberger, B Metzner, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 27, 2009
Nilotinib in the treatment of advanced gastrointestinal stromal tumours resistant to both imatinib and sunitinib
M Montemurro, P Schöffski, P Reichardt, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 13, 2011
An open-label, multicentre biomarker-oriented AIO phase II trial of sunitinib for patients with chemo-refractory advanced gastric cancer
M Moehler, A Mueller, J T Hartmann, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 28, 2005
Adjuvant chemoradiation using 5-fluorouracil/folinic acid/cisplatin with or without paclitaxel and radiation in patients with completely resected high-risk gastric cancer: two cooperative phase II studies of the AIO/ARO/ACO
C Kollmannsberger, W Budach, M Stahl, et al.
Page
of 12
Search research articles
Search
Showing results (91-100 of 114) with videos related to
Sort By:
Page
of 12
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 25, 2000
First-line high-dose chemotherapy +/- radiation therapy in patients with metastatic germ-cell cancer and brain metastases
C Kollmannsberger, C Nichols, M Bamberg, et al.
Cancer
|
April 3, 2001
Extragonadal seminoma: an international multicenter analysis of prognostic factors and long term treatment outcome
C Bokemeyer, J P Droz, A Horwich, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 25, 2011
The validation of matrix metalloproteinase-9 mRNA gene expression as a predictor of outcome in patients with metastatic gastric cancer
S-E Al-Batran, C Pauligk, R Wirtz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 17, 2001
Second-line chemotherapy in patients with relapsed extragonadal nonseminomatous germ cell tumors: results of an international multicenter analysis
J T Hartmann, L Einhorn, C R Nichols, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 26, 2003
Analysis of salvage treatments for germ cell cancer patients who have relapsed after primary high-dose chemotherapy plus autologous stem cell support
C Kollmannsberger, N Schleucher, O Rick, et al.
Journal of the National Cancer Institute
|
November 22, 2001
Incidence of metachronous testicular cancer in patients with extragonadal germ cell tumors
J T Hartmann, S D Fossa, C R Nichols, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 22, 2003
Long-term results of first-line sequential high-dose etoposide, ifosfamide, and cisplatin chemotherapy plus autologous stem cell support for patients with advanced metastatic germ cell cancer: an extended phase I/II study of the German Testicular Cancer Study Group
H-J Schmoll, C Kollmannsberger, B Metzner, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 27, 2009
Nilotinib in the treatment of advanced gastrointestinal stromal tumours resistant to both imatinib and sunitinib
M Montemurro, P Schöffski, P Reichardt, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 13, 2011
An open-label, multicentre biomarker-oriented AIO phase II trial of sunitinib for patients with chemo-refractory advanced gastric cancer
M Moehler, A Mueller, J T Hartmann, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 28, 2005
Adjuvant chemoradiation using 5-fluorouracil/folinic acid/cisplatin with or without paclitaxel and radiation in patients with completely resected high-risk gastric cancer: two cooperative phase II studies of the AIO/ARO/ACO
C Kollmannsberger, W Budach, M Stahl, et al.
Page
of 12